Albert Bourla Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Pfizer's Third-Quarter Results Reflect Confidence and Momentum
Pfizer reported third-quarter 2026 results on November 3 that exceeded the company’s expectations. The company’s commercial performance globally and continued financial discipline led to it raising its financial outlook for the year. With commercial momentum building and a robust slate of expected catalysts ahead, the company is focused on returning to growth toward the end of the decade.See below for key highlights. More details on Pfizer’s third-quarter 2026 earnings results and financial...
October Social Media Round-Up—Science Will Win, Values Day, and More
The seasons are changing and the weather is getting cooler, but our social media round-up is hot off the presses. As usual, we are sharing the latest and greatest updates from the last month. In October, we teased the launch of the next season of our award-winning podcast "Science Will Win," celebrated Pfizer's inclusion in Fortune's AIQ 75 list, and lit up our global offices for Light Up MBC. CEO Albert Bourla celebrated Values Day at Pfizer and his induction into the American Academy of Arts...
Pfizer Learns to Speak AI with Fluency Program
Technology moves fast, and there’s no better example than the rapid growth of artificial intelligence (AI).Here at Pfizer, we have long been focused on making breakthroughs that change patients’ lives. As new technology like AI emerges that can help us pursue our goals, we are committed to learning how best to apply AI to help make those breakthroughs even more quickly and efficiently. CEO Albert Bourla is leading the way with his vision for the future of Pfizer. His goal is to leverage AI...
September Social Media Round-Up—Prostate Cancer Awareness, TIME Executives of the Year, and More
As we enter fall, the days are getting shorter and the nights are getting cooler, but Pfizer’s social media channels are as active as ever.In September, we highlighted Blood and Prostate Cancer Awareness months, shared insights into how Pfizer’s helping combat counterfeit medicines, and released new episodes of “What’s In My Lab.” Meanwhile CEO Albert Bourla met with breast cancer patients and health care workers in Kenya and paid tribute to those we lost on the 25th anniversary of 9/11. Our...
Bourla at Concordia: The Business of Better Health
Each September, government officials, global executives, NGOs and other key leaders converge on New York for the United Nations General Assembly. The week is marked by direct, cross-sector dialogues about the state of the world and how we can plan for a prosperous future.At the 2026 Concordia Annual Summit, Albert Bourla joined that conversation via a mainstage discussion with Alice Park, senior health correspondent at TIME, titled "The Business of Better Health."As the global population ages...
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.In August, we highlighted the importance of our manufacturing systems, leveraged a new AI tool in our supply chain, and released a new episode of "What's In My Lab."Meanwhile, CEO Albert Bourla shared our second quarter results, shared how Pfizer is taking on AI adoption, and sat down with TIME...
How Pfizer Thinks About AI
At Pfizer, our ambition is to be the most AI-forward company in our industry, and we are making great progress every day. I spend more time thinking about it than almost anything else because I believe this is an unprecedented opportunity. AI will fundamentally improve how we discover medicines, how we develop and manufacture them and how quickly we reach patients. Very few technologies can change every corner of a business in this way.AI adoption is one thing — nearly every company has done it...
July Social Media Round-Up—America 250, Pfizer Futures, and More
Even amidst the cookouts, fireworks, and vacations, Pfizer remains hard at work all summer long, and July was no different.Last month, we held important conversations around living with alopecia areata, shared the story of a Pfizer colleague and cancer survivor, and reflected on the changes in science over the years.CEO Albert Bourla celebrated America’s 250th birthday, shared advice for our outgoing Pfizer Futures class, and congratulated the World Cup winners. While our leadership team shared...
June Social Media Round-Up—2025 Impact Report, ADA 2026, and More
School is out for the summer, but Pfizer colleagues are still hard at work. In June, we released our 2025 Impact Report, shared risks of fake medicines on World Anti-Counterfeit Day, and raised awareness of menstrual-related migraine and more.Pfizer has also been present at many conferences this past month—from ASCO and ADA to EHA and AHS 2026, and our leadership team has been highlighting the latest data that we’ve shared at these events. Meanwhile, CEO Albert Bourla joined the CNBC CEO Council...
Pfizer's 2025 Impact Report Highlights Progress Across Patients, Planet, and Responsible Business
Here at Pfizer, we are in the business of breakthroughs, and while our focus is on making advancements that impact patients’ lives, we are also aware of our work’s broader impact on the world. Every year, we take stock of the impact our work has on the world, the environment, and people themselves in our Impact Report.The 2025 Impact Report provides an overview of Pfizer's priorities and goals related to responsible business growth, which are aimed at contributing to long-term value creation and...
May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.May has been chock full of highlights—from sharing the latest data across our cancer work at ASCO 2026 to a feature in TIME highlighting how we bring science from the lab to life, we’re offering looks behind the science of Pfizer’s research. Next, review Pfizer’s first quarter results, courtesy of CEO Albert Bourla...
Building an AI-Fluent Organization: How Pfizer is helping colleagues understand, embrace, and apply AI
Pfizer has been utilizing artificial intelligence (AI) across our business for some time, but recent advancements in technology combined with advancements in biology are converging to create a scientific renaissance set to transform health as we know it. That reality is already upon us.According to Pfizer CEO Albert Bourla, the biggest barrier to unlock this potential is fear of the unknown. "It is not a question of technology," Bourla said in a recent conversation with Nikolai Tangen of the...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.